ß‐Tricalcium Phosphate Implants in the Surgical Treatment of Empty Nose Syndrome

Abstract

The objective of this study was to assess the efficacy and morbidity of a β-tricalcium phosphate implant in the treatment of empty nose syndrome after turbinectomy. Only patients with a history of inferior turbinectomy and a complaint of permanent paradoxical nasal obstruction were included. β-Tricalcium phosphate ceramic implants were implanted under the mucoperiosteal plane of the lateral nasal wall to replace the head of the inferior turbinate. Symptoms and quality of life were assessed by 2 questionnaires: the Nasal Obstruction Symptom Evaluation and Rhinosinusitis Quality of Life. Fourteen patients were included. The mean follow-up was 19.4 ± 13.4 months. Scores for the Nasal Obstruction Symptom Evaluation and Rhinosinusitis Quality of Life (frequency, bothersomeness, and impact) significantly improved after surgery (respectively, 73.9 ± 21.8 to 34.6 ± 28.6, 44.6 ± 17.1 to 34.8 ± 20.3, 43.6 ± 22.4 to 70.7 ± 21.5, and 59.9 ± 21.1 to 27.2 ± 25.3; P < .05). The use of ß-tricalcium phosphate seems efficient to repair empty nose syndrome by endonasal microplasty and shows a low complication rate.

Numerical simulation of two consecutive nasal respiratory cycles: toward a better understanding of nasal physiology

“…It may be argued that patients suffering from empty nose syndrome (ENS) no longer perceive 1 or several of these types of information, thereby having an impression of nasal obstruction. On the other hand, rebuilding the head of the inferior turbinate seems to improve the symptoms and quality of life of patients suffering from ENS …”

Analyses of the inferior turbinate using 3D geometric morphometrics: an anatomical study and discussion of the potential clinical implications

“…Functional outcomes estimated with the SNOT-25 score, showed significant improvement after a 12-week follow-up, SNOT-25 decreased from 77 to 55. Bastier et al (18) reported similar results: they used a b-tricalcium phosphate implant in 14 patients. Quality-of-life (frequency, bothersomeness, impact) significantly improved after surgery.…”

Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique

“…Numerous different nonresorbable filler materials and implants have been previously used in both these entities: autologous costal/septal/ conchal cartilage, 14,15 acellular dermis graft, 2 plastipore plates, 16 and ß-tricalcium phosphate, 17 goretex, or teflon implants. Cartilage graft has the advantage of being an autologous material, with excellent tolerance and integration, but implies a new mucosal trauma by removing septal cartilage and adds donor-site morbidity with costal or conchal grafts.…”